Breaking News Instant updates and real-time market news.

AYTU

Aytu BioScience

$1.41

-0.01 (-0.70%)

, INNV

Innovus Pharmaceuticals

$0.00

(0.00%)

08:11
09/12/19
09/12
08:11
09/12/19
08:11

Aytu BioScience announces agremeent to acquire Innovus Pharmaceuticals

Aytu BioScience (AYTU) and Innovus Pharmaceuticals (INNV) announced that the companies have signed a definitive merger agreement whereby Aytu will retire all outstanding common stock of Innovus for an aggregate of up to $8M in shares of Aytu common stock, less certain deductions, at the time of closing. This initial consideration to Innovus common shareholders is estimated to consist of approximately 4.2 million shares of Aytu stock. Additional consideration for up to $16M in milestone payments in the form of contingent value rights may be paid to Innovus shareholders in cash or stock over the next five years if certain revenue and profitability milestones are achieved. Innovus generated more than $24M in revenue in the four quarters ending June 30, 2019. Initially, the company expects to operate the commercial aspects of the Innovus consumer business separately from Aytu's prescription business, while rationalizing general and administrative expenses through the removal of Innovus' public company costs and redundant administrative and operational processes, along with the reduction in overhead, administrative and facilities costs. The board of directors of both companies have approved the terms of the merger transaction which is subject to the approval of both companies' shareholders. At the time of signing, Aytu had collected voting agreements supporting the merger transaction that represent approximately 35% of current shares outstanding. Innovus has thus far collected voting agreements supporting the transaction that represent approximately 17% of shares outstanding. The transaction, which is expected to close as early as Aytu's second fiscal quarter of 2020 and is subject to customary closing conditions and regulatory approvals.

AYTU

Aytu BioScience

$1.41

-0.01 (-0.70%)

INNV

Innovus Pharmaceuticals

$0.00

(0.00%)

AYTU Aytu BioScience
$1.41

-0.01 (-0.70%)

10/22/18
NORL
10/22/18
INITIATION
Target $10
NORL
Outperform
Aytu BioScience initiated with an Outperform at Northland
Northland analyst Carl Byrne initiated Aytu BioScience with an Outperform and $10 price target.
INNV Innovus Pharmaceuticals
$0.00

(0.00%)

05/21/19
HCWC
05/21/19
INITIATION
Target $5
HCWC
Buy
Innovus Pharmaceuticals initiated with a Buy at H.C. Wainwright
H.C. Wainwright analyst Vernon Bernardino started Innovus Pharmaceuticals with a Buy rating and $5 price target. The company has demonstrated capabilities that mimic the operations of major over-the-counter drug makers, Bernardino tells investors in a research note.

TODAY'S FREE FLY STORIES

HLT

Hilton

$90.81

-1.57 (-1.70%)

06:11
10/23/19
10/23
06:11
10/23/19
06:11
Earnings
Hilton sees Q4 adjusted EPS 91c-96c, consensus 99c »

Sees Q4 management and…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Oct

  • 06

    Nov

FCFS

First Cash Financial

$94.76

-0.19 (-0.20%)

06:10
10/23/19
10/23
06:10
10/23/19
06:10
Earnings
First Cash Financial reports Q3 adjusted EPS 84c, consensus 84c »

Reports Q3 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Nov

DIS

Disney

$132.44

2.16 (1.66%)

06:10
10/23/19
10/23
06:10
10/23/19
06:10
Periodicals
Disney defends Marvel movies, discusses succession planning, WSJ reports »

Disney CEO Robert Iger…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Oct

  • 24

    Oct

  • 07

    Nov

HLT

Hilton

$90.81

-1.57 (-1.70%)

06:10
10/23/19
10/23
06:10
10/23/19
06:10
Earnings
Hilton raises FY19 adjusted EPS view to $3.81-$3.86 from $3.78-$3.85 »

Consensus for FY19 EPS is…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Oct

  • 06

    Nov

BIIB

Biogen

$281.96

58.39 (26.12%)

06:09
10/23/19
10/23
06:09
10/23/19
06:09
Upgrade
Biogen rating change  »

Biogen upgraded to Buy…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CRWD

Crowdstrike

$46.15

-1.1 (-2.33%)

06:08
10/23/19
10/23
06:08
10/23/19
06:08
Initiation
Crowdstrike initiated  »

Nomura Instinet starts…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Dec

AXLA

Axcella

$5.23

-0.075 (-1.42%)

06:07
10/23/19
10/23
06:07
10/23/19
06:07
Conference/Events
Axcella management to meet with SVB Leerink »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Oct

  • 25

    Oct

  • 08

    Nov

BANC

Banc of California

$15.02

-0.015 (-0.10%)

06:07
10/23/19
10/23
06:07
10/23/19
06:07
Earnings
Banc of California reports Q3 EPS (45c), consensus (34c) »

The net loss available to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Oct

  • 06

    Nov

HLT

Hilton

$90.81

-1.57 (-1.70%)

06:07
10/23/19
10/23
06:07
10/23/19
06:07
Earnings
Hilton reports Q3 adjusted EPS $1.05, consensus $1.02 »

Reports Q3 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Oct

  • 06

    Nov

TMO

Thermo Fisher

$280.89

-2.56 (-0.90%)

06:07
10/23/19
10/23
06:07
10/23/19
06:07
Earnings
Thermo Fisher raises FY19 adj. EPS view to $12.28-$12.34 from $12.16-$12.26 »

Consensus $12.25. Raises…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Oct

  • 06

    Nov

  • 02

    Dec

  • 07

    Dec

FB

Facebook

$182.27

-7.55 (-3.98%)

06:07
10/23/19
10/23
06:07
10/23/19
06:07
Hot Stocks
Facebook to tell Congress that Libra to 'extend America's financial leadership' »

Facebook CEO Mark…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Oct

  • 27

    Oct

  • 30

    Oct

ANTM

Anthem

$260.28

7.12 (2.81%)

06:06
10/23/19
10/23
06:06
10/23/19
06:06
Hot Stocks
Anthem sees FY19 medical membership approximately 41M »

Medical membership is now…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Oct

CMG

Chipotle

$831.69

-20.195 (-2.37%)

06:06
10/23/19
10/23
06:06
10/23/19
06:06
Recommendations
Chipotle analyst commentary  »

Chipotle bull case…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Nov

ANTM

Anthem

$260.28

7.12 (2.81%)

06:05
10/23/19
10/23
06:05
10/23/19
06:05
Earnings
Breaking Earnings news story on Anthem »

Anthem sees FY19 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Oct

FMS

Fresenius Medical

$32.21

-2.05 (-5.98%)

06:03
10/23/19
10/23
06:03
10/23/19
06:03
Downgrade
Fresenius Medical rating change  »

Redburn downgrades…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    Oct

KSS

Kohl's

$52.96

1.72 (3.36%)

06:03
10/23/19
10/23
06:03
10/23/19
06:03
Downgrade
Kohl's rating change  »

Kohl's downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Nov

TMO

Thermo Fisher

$280.89

-2.56 (-0.90%)

06:03
10/23/19
10/23
06:03
10/23/19
06:03
Earnings
Thermo Fisher reports Q3 adj. EPS $2.94, consensus $2.87 »

Reports Q3 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Oct

  • 06

    Nov

  • 02

    Dec

  • 07

    Dec

ING

ING Group

$11.52

-0.04 (-0.35%)

06:03
10/23/19
10/23
06:03
10/23/19
06:03
Downgrade
ING Group rating change  »

ING Group downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 31

    Oct

OC

Owens Corning

$63.41

-0.055 (-0.09%)

06:02
10/23/19
10/23
06:02
10/23/19
06:02
Hot Stocks
Owens Corning provides 2019 outlook »

"The company's…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Oct

REZI

Resideo

$15.17

0.03 (0.20%)

06:02
10/23/19
10/23
06:02
10/23/19
06:02
Downgrade
Resideo rating change  »

Resideo downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

OC

Owens Corning

$63.41

-0.055 (-0.09%)

06:01
10/23/19
10/23
06:01
10/23/19
06:01
Earnings
Owens Corning reports Q3 adjusted EPS $1.63, consensus $1.50 »

Reports Q3 revenue $1.9B,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Oct

ANTM

Anthem

$260.28

7.12 (2.81%)

06:01
10/23/19
10/23
06:01
10/23/19
06:01
Earnings
Anthem raises FY19 adjusted EPS view to greater than $19.40 per share »

Prior view was greater…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Oct

ANTM

Anthem

$260.28

7.12 (2.81%)

06:00
10/23/19
10/23
06:00
10/23/19
06:00
Earnings
Anthem reports Q3 adjusted EPS $4.87, consensus $4.82 »

Reports Q3 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Oct

KO

Coca-Cola

$53.87

-0.37 (-0.68%)

05:56
10/23/19
10/23
05:56
10/23/19
05:56
Upgrade
Coca-Cola rating change  »

Coca-Cola upgraded to Buy…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

STOK

Stoke Therapeutics

$23.02

0.47 (2.08%)

05:55
10/23/19
10/23
05:55
10/23/19
05:55
Conference/Events
Stoke Therapeutics management to meet with JPMorgan »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Oct

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.